The Epstein–Barr virus BFRF1 and BFLF2 proteins interact and coexpression alters their cellular localization  by Lake, Cathleen M & Hutt-Fletcher, Lindsey M
www.elsevier.com/locate/yviro
Virology 320 (2004) 99–106The Epstein–Barr virus BFRF1 and BFLF2 proteins interact and
coexpression alters their cellular localization
Cathleen M. Lake1 and Lindsey M. Hutt-Fletcher*
School of Biological Sciences, University of Missouri-Kansas City, Kansas City, MO, USAReceived 4 September 2003; returned to author for revision 13 November 2003; accepted 14 November 2003Abstract
The BFRF1 protein of Epstein–Barr virus (EBV) is a recently identified membrane protein that is the homolog of the alphaherpesvirus
UL34 gene product. We report here that a yeast two-hybrid screen identified the BFLF2 gene product, a homolog of alphaherpesvirus UL31,
as a protein that interacts with BFRF1. Expression of BFLF2 in mammalian cells revealed a protein of approximately 28 kDa that associated
with BFRF1 in a noncovalently linked complex. When expressed alone, the BFRF1 protein was found in the cytoplasm and perinuclear
region. BFLF2 was found diffusely in the nucleus in the absence of BFRF1, but coexpression of BFRF1 and BFLF2 resulted in
colocalization of the two proteins at the nuclear rim. These data recapitulate the behavior of the alphaherpesvirus homologs of BFRF1 and
BFLF2 and suggest that functional as well as structural and positional homology may be conserved.
D 2004 Elsevier Inc. All rights reserved.Keywords: Epstein–Barr virus; Cellular localization; CoexpressionIntroduction
Epstein–Barr virus (EBV) is a gammaherpesvirus that is
carried by more than 95% of the adult population worldwide
(Henle and Henle, 1979). Although many people suffer no
ill-effects as a result, primary infections can be accompanied
by acute infectious mononucleosis and long-term carriage
may be associated with both lymphoid and epithelial ma-
lignancies. Among these are immunoblastic lymphoma,
Burkitt’s lymphoma, Hodgkin’s disease, nasopharyngeal
carcinoma, gastric cancer, and possibly breast cancer
(Rickinson and Kieff, 2001). Each disease, including
infectious mononucleosis, involves either a response to or
the growth of a cell that is latently infected with EBV. Much
of the research into the biology and pathogenesis of EBV
has thus appropriately focused on the establishment and
consequences of latency. The unintended consequence is
that less is known about some of the important lytic cycle0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2003.11.018
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50th Street, Kansas City, MO 64110 USA.proteins of EBV than about those of other herpesviruses,
particularly the alphaherpesviruses that more readily under-
go lytic replication.
The basic strategy of replication is shared among the
herpesviruses and many insights into the potential functions
of EBV-encoded proteins have come from knowledge of the
functions of proteins of other herpesviruses that appear to
have been conserved either in sequence, structure, or genomic
organization. However, some apparently well-conserved
proteins have proven to mediate surprisingly different func-
tions. For example, the glycoprotein gB of herpes simplex
virus (HSV) and other alphaherpesviruses plays an important
role in virus entry, but is dispensible for virus assembly and
egress (Roizman and Knipe, 2001). In contrast, while EBV
glycoprotein gB is probably required for virus cell fusion
(Haan et al., 2001), it also plays a critical role in capsid
formation and virus release (Herrold et al., 1995; Lee and
Longnecker, 1997). Similarly, although the glycoprotein
gNgM complex of alphaherpesviruses is not essential for
replication, the EBV gNgM shows no redundancy with other
virus proteins and its loss significantly impairs formation of
enveloped virions (Lake and Hutt-Fletcher, 2000).
Two newly studied interactive alphaherpesvirus proteins
(Fuchs et al., 2002; Ye and Roizman, 2000) that are
conserved in all the herpesvirus subfamilies are the UL31
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1990; McGeoch et al., 1988). Expression of these proteins is
required for efficient envelopment of alphaherpesviruses at
the nuclear membrane (Chang et al., 1997; Fuchs et al.,
2001, 2002; Klupp et al., 2000; Shiba et al., 2000) and the
cytomegalovirus (CMV) homologs, which also interact,
recruit cellular kinases for phosphorylation and dissolution
of the nuclear lamina (Muranyi et al., 2002). UL34 is
predicted to be, and in HSV is, a type II membrane protein
(Shiba et al., 2000), whereas UL31 is not predicted to have
any transmembrane domains and in herpes simplex virus is
a phosphoprotein that associates with the nuclear matrix
(Chang and Roizman, 1993). The nuclear localization of
UL31 family members studied to date is an intrinsic
property of the proteins, but association with UL34 influ-
ences the distribution of both partners. UL31, when
expressed independently, is found throughout the nucleus,
but when expressed with UL34 is found at the nuclear rim.Fig. 1. Cloning strategies. (A) Organization of the BamH1 F fragment of EBV. (B
from the BamH1 F fragment of EBV DNA with primers P1 and P2 and cloned in
domain (GAL4 AD) to make pGADT7-HA-BFLF2. HA-tagged BFLF2 was cut fro
(Right side, top) Rightward-reading BFRF1 open reading frame was amplified from
transmembrane domain (hatched bar), and cloned into pAS-2 in frame with the GA
open reading frame was also amplified with primers P3 and P5, which contained
create pTM1-BFRF1-Flag. The library made from Akata cells induced to produce E
HA. The numbering of the base pairs refers to the B95-8 sequence.When UL34 is expressed independently, it is found in the
nucleus envelope and cytoplasm, whereas in association
with UL31 it colocalizes to the nuclear rim (Fuchs et al.,
2002; Reynolds et al., 2001). Farina et al. (2000) recently
reported that the BFRF1 gene of EBV encodes a non-
glycosylated early or late protein that migrates as a doublet
of approximately 37–38 kDa. The protein was found
predominantly on nuclear membranes of virus-producing
cells, although some expression was seen in the cytoplasm
and on the plasma membrane and was also present in
extracellular virions. In view of the studies done with the
BFRF1 homologs in other herpesviruses we sought to
determine if the EBV protein also interacted with the
EBV UL31 homologue BFLF2. We report here that the
two proteins form a stable association that, as in the
alphaherpesviruses, influences the intracellular localization
of each and is compatible with a similar role for the complex
in primary virion envelopment., left side, top) Leftward-reading BFLF2 open reading frame was amplified
to pGADT7 in frame with an HA tag (black bar) and the GAL4 activation
m pGADT7-HA-BFLF2 and cloned into pTM1 to make pTM1-HA-BFLF2.
BamH1 F with primers P3 and P4, cut with Sma1 to remove the predicted
L4 DNA-binding domain (GAL4 AD) to make pAS2-1-BFRF1. The BFRF1
sequences encoding a Flag epitope (checked bar), and cloned into pTM1 to
BV was recombined into pGADT7-Rec to fuse sequences to GAL4-AD and
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Interaction of BFRF1 and BFLF2 gene products in yeast
two-hybrid analyses
The genomic organization of the BamH1 F fragment is
shown in Fig. 1A. The rightward-reading BFRF1 open
reading frame is predicted to encode a 336-amino acid
protein with a potential transmembrane domain between
residues 317 and 333. The expected topology of the protein
is that of a type-II membrane protein with a long cytoplasmic
tail extending from residues 1 to 317 and an extremely short
luminal domain. Because only the cytoplasmic tail might be
expected to interact with a nuclear protein such as a homolog
of the UL31 protein, the BFRF1 open reading frame,
truncated at residue 317, was amplified from the EBV
BamH1 F fragment and cloned downstream of the GAL4
DNA-binding domain to make pAS2-1-BFRF1 (Fig. 1B)
and rescued into the yeast strain Y187. A cDNA library was
constructed in yeast strain AH109 from mRNA isolated from
Akata cells in which approximately 60% of the cells had
been induced into the EBV lytic cycle. AH109 and Y187
cells were mated to screen for proteins that were interactive
with BFRF1. Fifty-one colonies grew out on selective
medium indicating that they had simultaneously activated
the TRP and LEU genes in the plasmids and also the HIS3
and ADE2 genes under control of the GAL4 promoter. Of
these, 28 also activated GAL4-driven MEL1 as judged by
secretion of h-galactosidase. Plasmids from eight coloniesFig. 2. SDS-PAGE and autoradiography of [35S] methionine-labeled proteins imm
transfected with pTM1-BFRF1-Flag alone, pTM1-HA-BFLF2 alone, or pTM1
molecular weight markers.were rescued into bacteria for sequencing and the three from
which sequence was successfully obtained mapped to the
BFLF2 open reading frame (two at nt 56933–56762 and
one at nt 56837–56778). Although the cDNAs had origi-
nally been transcribed with oligo dT primers and contained
sequences large enough to contain the entire open reading
frame, the interaction was reevaluated by amplifying the full-
length leftward-reading open reading frame, the BamH1 F
fragment cloning it into pGADT7, rescuing it into AH109,
and remating the new transformant with pAS2-1-BFRF1 in
Y187 under selection as described above. Colonies were
visible at 5 days whereas the same cells mated with partners
containing either of the empty vectors failed to activate
expression of HIS3, ADE2, or MEL1.
Interactions between full-length BFRF1 and BFLF2
proteins expressed in mammalian cells
To obtain biochemical confirmation of an interaction
between the BFRF1 and BFLF2 proteins, full-length con-
structs of each were cloned for high-level expression into
the pTM1 vector under control of a T7 promoter. A Flag
epitope was added to the carboxy terminus of BFRF1 and
the BFLF2 protein retained the amino terminal HA tag that
had been added when it was cloned into the yeast vector
pGADT7. CV1 cells were transfected with combinations of
the constructs and concurrently infected with a vaccinia
virus expressing the T7 polymerase. A monoclonal antibody
to the Flag epitope, but not a monoclonal antibody to theunoprecipitated with Mab to HA (HA) or Mab to Flag (FL) from CV-1 cells
-BFRF1-Flag and pTMI-HA-BFLF2 together. Numbers on the right are
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approximately 32–34 kDa from cells transfected with
pTM1-BFRF1-Flag and labeled with [3H] leucine (Fig.
2). A monoclonal antibody to HA, but not the monoclo-
nal antibody to Flag, immunoprecipitated a protein of
approximately 28 kDa from cells transfected with pTM1-
HA-BFLF2. Both antibodies immunoprecipitated both the
32–34-kDa doublet and the 28-kDa protein from cells
cotransfected with pTM1-BFRF1-Flag and pTM1-HA-
BFLF2, confirming that the two full-length proteins
interact. A larger amount of the BFLF2 protein could
be immunoprecipitated from cells cotransfected with
BFRF1. Scanning of an exposure of the autoradiograph
in the linear range indicated that the steady-state level of
BFLF2 was increased 2.4-fold in the presence of BFRF1.Fig. 3. Staining of CV-1 cells transfected with pTM1-BFRF1-Flag alone (A, B,
pTMI-HA-BFLF2 (G–I). Panels A–D are photomicrographs of cells stained with
those of the same cells stained with DAPI. Panels E–I are digital confocal images o
F and H) and a merge of panels G and H (panel I).Effects of coexpression on the cellular localization of
BFRF1 and BFLF2 proteins
In the absence of UL31, the alphaherpesvirus UL34
protein is found in the cytoplasm and perinuclear region; in
the absence of UL34, the UL31 protein is found diffusely
in the nucleus. To determine if the EBV counterparts of
UL34 and UL31 behaved in the same way, CV1 cells were
transfected with either construct, stained with the appropri-
ate monoclonal antibody, and counterstained with DAPI to
visualize the nuclei. When expressed alone, the BFRF1
protein was found in the cytoplasm and around the nucleus,
but was excluded from the nucleus itself as indicated by no
overlap of antibody and DAPI staining (Fig. 3). In contrast,
the BFLF2 protein was confined to the nucleus as con-
irology 320 (2004) 99–106and E), pTM1-HA-BFLF2 (C, D, and F), or both pTM1-BFRF1-Flag and
anti-Flag (A) or anti-HA (C); B and D are images in A and C merged with
f cells stained with anti-Flag (red, panels E and G) or anti-HA (green, panels
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graphs of antibody and DAPI staining were merged. To
examine the effects of coexpression of BFRF1 and BFLF2
on protein localization, cells were transfected with one or
the other or both BFRF2- and BLFL2-expressing plasmids,
stained with antibodies to HA, to Flag, or to both, and
viewed by confocal microscopy. As before, the BFRF1
protein was cytoplasmic and perinuclear when expressed
alone, and the BFLF2 protein was restricted to the nucleus.
However, when the proteins were coexpressed, the proteins
colocalized to the nuclear rim in approximately 90% of the
cells. Staining fully encompassed the nuclear rim, although
the staining was slightly punctate. In the minority of cells
in which localization to the nuclear rim did not occur, both
BFRF1 and BFLF2 staining were seen diffusely in the
cytoplasm.Discussion
The genomic organization of the BFRF1 and BFLF2
genes of EBV is similar to that of the UL34 and UL31
genes of the alphaherpesvirus and the genes are consid-
ered to be homologs. The results presented here indicate
that the proteins of the two different subfamilies, which
are predicted to be similar in structure, also share behav-
ioral traits that are consistent with similar roles in virus
replication.
The BFRF1 open reading frame has previously been
reported to encode a doublet that migrates with an apparent
mass of 37–38 kDa (Farina et al., 2000). The mass of the
doublet reported here, 32–34 kDa, is slightly smaller than
this, but given potential differences in electrophoresis
conditions is reasonably consistent with the previous re-
port. The BFLF2 open reading frame is predicted, but not
known, to express a protein of approximately 35 kDa. The
epitope-tagged protein expressed here is approximately 28
kDa. Both the yeast two-hybrid data and the biochemical
analyses indicate that like their counterparts in other
herpesviruses the BFRF1 and BFLF2 proteins interact.
Coprecipitation is possible in the presence of sodium
dodecyl sulfate. Coexpression has no effect on the mobility
of either protein, but in the presence of BFRF1, the BFLF2
protein appears to be slightly more stable. A similar effect
has been reported for the UL34 and UL31 proteins,
perhaps more striking because it was studied in the context
of HSV replication where UL31 becomes particularly
susceptible to proteasomal digestion in the absence of
UL34 (Ye and Roizman, 2000). The dramatic effects of
coexpression on the cellular localization of UL31 and
UL34 are also recapitulated for BFRF1 and BFLF2.
Expressed in isolation, UL31 and UL34 of HSV colocalize
at the nuclear rim in the same punctate pattern as seen here.
In virus-infected cells, however, staining is more uniform.
Expression of the US3 kinase in addition to UL31 and
UL34 is required to reproduce the same even stainingpattern in transfected cells. This is consistent with a
requirement for phosphorylation of UL34 by US3 because,
in its absence, localization of UL34 to the nuclear mem-
brane is also delayed (Reynolds et al., 2001). Farina et al.
(2000) show photomicrographs in which BFRF1 staining
in infected cells also appears to be more uniform that the
staining seen here, although detailed comparisons of con-
ventional and confocal microscopy are difficult to evaluate
and as yet we have no reagents with which either native
BFRF1 or BFLF2 can be visualized in virus-producing
cells. EBV encodes no homolog to US3, but the BGLF4
open reading frame encodes a kinase that is a homolog of
the human cytomegalovirus UL97 kinase. UL97 is required
for efficient nuclear egress of human CMV and UL34 has
been suggested to be a potential target for UL97 (Krosky et
al., 2003). Preliminary experiments in which a BGLF4
expression plasmid was cotransfected with BFRF1 and
BFLF2 did not show any change in protein distribution
and neither BFRF1 nor BFLF2 was phosphorylated in
either the presence or absence of BGLF4 (data not shown),
but it is also possible that as in murine CMV the punctate
pattern of staining is the normal distribution (Muranyi et
al., 2002).
Current models of herpes virus assembly and egress
propose that the capsid first acquires an envelope as it buds
through the inner nuclear membrane. De-enveloped nucle-
ocapsids are then delivered to the cytoplasm by fusion with
the outer nuclear membrane or that of the endoplasmic
reticulum with which it is contiguous. The final envelope
is acquired by rebudding into a cytoplasmic compartment,
probably the trans-Golgi network, that puts the virus back in
a later stage of the exocytic pathway (Mettenleiter, 2002).
Alphaherpesviruses UL31 and UL34 have been shown to
play a critical role in egress from the nucleus, and enveloped
virions in the perinuclear space contain UL34. There are,
however, conflicting reports as to the complete distribution
of UL34 during virus replication. UL34 has variously been
reported as detectable only at the nuclear membrane and in
the envelope of virus in the perinuclear space (Fuchs et al.,
2002; Klupp et al., 2000; Reynolds et al., 2001, 2002),
which is consistent with a model in which primary and
secondary envelopes differ in content as well as site of
acquisition, or as present in nuclear membranes and in the
extracellular virus (Purves et al., 1992; Shiba et al., 2000).
The latter is consistent with observations suggesting that
UL34 interacts with dynein and is important to the intracel-
lular transport of incoming virus (Ye et al., 2000). Farina et
al. (2000) reported that during virus replication, the BFRF1
protein was not only detected predominantly at the nuclear
membrane, but could also be seen at the plasma membrane
and in the virus. Expressed as a recombinant protein, we
confirm the strong association with the nuclear envelope,
but find no evidence for expression of BFRF1 at the plasma
membrane, although the distinction between nuclear and
plasma membrane is clearer in epithelial cells in which we
expressed the protein than it is in the lymphocytes studied
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higher. It is also possible that expression in the context of
virus is different because of interactions with additional
virus proteins.
The only evidence pertinent to the envelopment or re-
envelopment model of egress for EBV comes from studies
of the distribution of EBV gB in the B958 strain of the virus
where gB is found predominantly in the membranes of the
nucleus and endoplasmic reticulum and mainly carries high
mannose sugars, consistent with a lack of processing in the
Golgi apparatus, whereas the virus attachment protein
gp350/220, which carries large amounts of Golgi-dependent
O-linked sugars, is primarily found in the plasma membrane
and Golgi. The virion envelope contains copious amounts
of gp350/220, but only very small amounts of a differen-
tially glycosylated form of gp110, gp125, that carries some
Golgi-modified sugars (Gong and Kieff, 1990). These data
are consistent with the sequential formation of two differ-
ently enveloped virions. The strikingly similar behavior of
the BFRF1–BFLF2 complexes and their homologs in
herpesviruses that have been more extensively studied
suggests that the roles of the UL34 and UL31 proteins in
virus egress may be recapitulated in EBV. Generation of a
recombinant EBV that is deleted for expression of either
BFRF1 or BFLF2 will help determine if these are proteins
that functionally similar to their counterparts or have
evolved different or additional roles in gammaherpesvirus
replication.Materials and methods
Mammalian and yeast cells
Akata, a Burkitt lymphoma-derived cell line that carries
and can be induced to make EBV (Takada and Ono, 1989),
was grown in RPMI 1640 (Sigma, St. Louis, MO) supple-
mented with 10% heat-inactivated fetal bovine serum
(Gibco/BRL, Grand Island, NY). CV-1 monkey kidney cells
were grown in Dulbecco’s modified Eagle’s medium con-
taining 10% heat-inactivated fetal bovine serum. Yeast
strain Y187 (BDClontech, Palo Alto, CA) contains the
reporters lacZ and MEL1 and the transformation markers
trp1 and leu2. Yeast strain AH109 (BDClontech) contains
the reporters HIS3, ADE2, lacZ, and MEL1 and the trans-
formation markers trp1 and leu2.
Antibodies
Mouse monoclonal antibodies used were anti-Flag-M2
(Sigma), HA.11 antibody to HA (Covance, Princeton, NJ),
and fluorescein-conjugated 12CA5 antibody to HA (Roche
Diagnostics, Indianapolis, IN). Secondary antibodies used
were goat anti-mouse IgG conjugated to Alexa Fluor 563
(Molecular Probes, Eugene, OR) and fluorescein-conjugated
sheep anti-mouse IgG (ICN/Cappel, Irvine, CA).Plasmids for yeast two-hybrid analysis
The BFLF2 ORF was amplified by a PCR method from
the BamH1 F fragment of B95.8 virus DNA (a gift of Clare
Sample, St. Jude Children’s Research Hospital). The 5V
primer P1 (GAT CGA TCA TAT GGC CCC GGT CAC C)
included the first ATG of the ORF and an Nde1 site. The 3V
primer P2 (GGC GGA TCC CTG TTTATT TTC C) included
a BamH1 site. The DNA amplified with these primers was
cut with Nde1 and BamH1 and inserted into pGADT7 that
was cut with the same enzymes to make the plasmid
pGADT7-BFLF2 in which BFLF2 was in frame with the
GAL4 activation domain. The BFRF1 ORF was also ampli-
fied by a PCR method from the BamH1 F fragment. The 5V
primer P3 (CTG GAA TTC CAT GGC GAG CCC GGA A)
included the first ATG of the ORF and both an EcoRI and a
NcoI site. The 3V primer P4 (GGC GGA TCC GGT CCA
CCT CAG AAA) included a BamH1 site. The DNA ampli-
fied with these primers was cut with NcoI and SmaI, which
cuts the ORF at nucleotide 894 and removes 114 nucleotides
of 3V sequence, and inserted into the pAS2-1 vector
(BDClontech) which had previously been cut with the same
enzymes to make plasmid pAS2-1-BFRF1.
Yeast two-hybrid library
Akata cells were induced at a concentration of 106 cells/
ml with 86 Ag/ml goat antihuman IgG (ICN/Cappel) for 12
h. Cells were pelleted, washed once in phosphate-buffered
saline, flash frozen in liquid N2, and stored at 85 jC.
RNA was extracted from cells using the Totally RNA
Isolation Kit (Ambion Inc, Austin, TX). cDNA synthesis
and library construction were carried out with the MATCH-
MAKER Library Construction and Screening Kit
(BDClontech) according to the manufacturer’s instructions.
In brief, approximately 2 Ag of RNA was used for first-
strand synthesis with oligo (dT) primers. cDNA was
amplified by PCR [95 jC/30 s, 23 (95 jC/10 s, 68 jC/
6 min increasing 5 s with each successive cycle) 68 jC/5
min], purified, and transformed into lithium acetate-com-
petent AH109 cells together with the plasmid pGADT7
Rec and carrier DNA. Transformants were selected on SD/-
Leu plates. Freezing media were added to each plate to
collect transformants and the library was aliquoted and
stored at 85 jC.
Yeast two-hybrid screens
pAS2-1-BFRF1 in Y187 was mated with the EBV lytic
cell library in pGADT7 following the protocol outlined in
the MATCHMAKER Library Construction and Screening
Kit. Colonies were grown on quadruple synthetic dropout
(SD) medium lacking tryptophan, leucine, histidine, and
adenine and screened for h-galactosidase activity in a
colony lift filter assay. Plasmids were isolated from yeast
cells with the Q Biogene RPM Yeast Plasmid Isolation Kit
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medium lacking leucine into Escherichia coli strain KC8
(BDClontech), which has a defect in leuB that can be
complemented by yeast LEU2. Plasmids were then rescued
back into strain DH5a for sequencing. cDNA sequences
were compared to known DNA and protein sequences using
the BLAST network service and sequence analysis software
of the National Center for Biotechnology Information.
pAS2-1-BFRF1 in Y187 and pGADT7-BFLF2 in AH109
were mated at 30 jC on quadruple dropout agar plates by
cross streaking.
Expression in the pTM1 vector
The BFRF1 ORF was amplified from the BamH1 F
fragment with the 5’ primer P3 (CTG GAA TTC CAT
GGC GAG CCC GGA A) that included the first ATG of
the ORF and both an EcoRI and an NcoI site and the 3V
primer P5 (CCG GAT CCT TAT CGT CGT CGT CCT TGT
AAT CGG TCC ACC TCA G) that included a flag tag and a
BamH1 site. The DNA amplified with these primers was cut
with NcoI and BamH1 and inserted into pTM1 (Moss et al.,
1990) that had previously been cut with the same enzymes
to make plasmid pTM1-BFRF1-Flag. The BFLF2 ORF was
cut from pGADT7-BFLF2 with NcoI and BamH1. The
ORF, now containing a HA tag in frame at the 5V end,
was inserted into pTM1 that had been cut with the same
enzymes to make the plasmid pTM1-HA-BFLF2. Plasmids
were transfected into CV1 cells 30 min after the cells had
been infected with vaccinia virus expression T7 at a
multiplicity of 5. For transfections of a single plasmid, 6
Ag of DNAwas mixed with 40 Al of Lipofectamine (Gibco/
BRL) made to a total volume of 800 Al with serum-free
medium. For transfection of two plasmids, 6 Ag of each was
used. Each mixture was incubated for 45 min at room
temperature before addition to cells.
Immunofluorescence and confocal microscopy
CV-1 cells that had been infected with vvT7 and trans-
fected with pTM1-BFRF1-Flag, pTM1-HA-BFLF2, or a
mixture of plasmids were air-dried on slides and fixed for
10 min in ice-cold acetone. For observation by fluorescence
microscopy, cells were incubated sequentially for 30 min at
37 jC with antibody specific for HA or Flag epitopes and
fluorescein-conjugated sheep anti-mouse IgG, stained with
DAPI at a final concentration of 300 AM for 5 min at 37 jC,
and mounted in DABCO. Cells were washed three times in
phosphate-buffered saline between each incubation. For
confocal laser scan microscopy, cells were incubated sequen-
tially with antibody specific for Flag, goat anti-mouse IgG
conjugated to Alexa Fluor 563, and fluorescein-conjugated
mouse anti-HA. Fluorescence was viewed with an Olympus
BX61 upright epifluorescence microscope coupled to an
Olympus Fluoview 300 confocal microscope and images
were digitized with the Fluoview program version 4.1.Radiolabeling and immunoprecipitation
CV-1 cells that had been infected with vvT7 and trans-
fected with pTM1-BFRF1-Flag, pTM1-HA-BFLF2, or a
mixture of plasmids were labeled with [3H] leucine as
previously described (Lake et al., 1998). Labeled cells were
solubilized in radioimmunoprecipitation buffer (50 mM
Tris–HCl, pH 7.2, 0.15 M NaCl, 1% Triton X-100, 1%
sodium deoxycholate, 0.1% sodium dodecyl sulfate, 0.1
mM phenylmethyl-sulfonylfluoride, and 100 U of Aprotinin
per ml) and immunoprecipitated with antibody and protein
A-Sepharose CL4B (Sigma). Immunoprecipitated proteins
were washed, dissociated by boiling for 2 min in sample
buffer with 2-mercaptoethanol, and analyzed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) in 10% polyacrylamide cross-linked with 0.28%
N,NV-diallyltartardiamide followed by fluorography.
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